Being overweight or obese has become a significant global health concern, even a worldwide epidemic, and may actually be viewed as chronic disease conditions. In addition to the necessary lifestyle modifications required to effect weight-loss, which constitutes an essential healthcare intervention in this patient population, the use of adjunctive pharmacotherapeutic agents is often required. This article provides an overview of new advances in the treatment of obesity and the role of the pharmacist in promoting weight-loss in this patient population.
|Number of pages||6|
|Journal||SA Pharmaceutical Journal|
|Publication status||Published - 1 Jan 2021|
- Type 2 diabetes mellitus